Journal rankings · indicator year 2016
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2016
Oncology journal rankings 2016
198 ranked journals · Subfield in Medicine
Oncology has 198 ranked journals in 2016. The median OJR fell 0.13 on 2015 to 0.83, below the world average of 1.00; Q1 starts at OJR 1.51. The top three are CA A Cancer Journal for Clinicians, The Lancet Oncology, and Nature Medicine.
Ranks and citation indicators: 2016. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2013–2015, the window the 2016 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery821
- Pulmonary and Respiratory Medicine315
- Public Health, Environmental and Occupational Health256
- Cardiology and Cardiovascular Medicine248
- Oncology198
- Infectious Diseases189
- Epidemiology187
- Endocrinology, Diabetes and Metabolism151
- Neurology151
- Radiology, Nuclear Medicine and Imaging142
- Psychiatry and Mental health134
- Physiology131
Show all 42 subfields
- Orthopedics and Sports Medicine102
- Pediatrics, Perinatology and Child Health91
- Ophthalmology80
- Dermatology78
- Hematology70
- Obstetrics and Gynecology64
- Rheumatology58
- Nephrology53
- Reproductive Medicine46
- Pharmacology44
- Complementary and alternative medicine43
- Emergency Medicine37
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation31
- Pathology and Forensic Medicine24
- Critical Care and Intensive Care Medicine23
- Hepatology21
- Genetics20
- Immunology and Allergy19
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology6
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
198 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2015. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2013–2015, the window the 2016 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2013–2015 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2007 to 2016. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 64.20Q1 | 185.98 46.55 up from 2015 | 80 | 100% | $4,330 | ||
2The Lancet OncologyElsevier BV · United Kingdom | 7.26Q1 | 18.07 1.36 up from 2015 | 1,107 | 27% | $7,280 | ||
3Nature MedicineNature Portfolio · United States | 6.81Q1 | 17.48 2.31 up from 2015 | 1,078 | 58% | $12,690 | ||
4Cancer CellCell Press · Netherlands | 6.32Q1 | 19.64 2.21 up from 2015 | 542 | 100% | $10,400 | ||
5Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.15Q1 | 14.68 0.92 up from 2015 | 2,287 | 5% | — | ||
6JAMA OncologyAmerican Medical Association · United States | 4.08Q1 | 8.15no 2015 value | 330 | 37% | — | — | |
7Annals of OncologyElsevier BV · Netherlands | 3.60Q1 | 10.19 1.26 up from 2015 | 1,423 | 87% | $5,080 | ||
8Seminars in Cancer BiologyElsevier BV · United States | 3.52Q1 | 9.80 0.04 up from 2015 | 200 | 28% | $6,060 | ||
9Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.38Q1 | 9.16 0.03 up from 2015 | 2,189 | 42% | — | ||
10Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 3.32Q1 | 8.90 0.85 up from 2015 | 342 | 10% | — | ||
11JNCI Journal of the National Cancer InstituteOxford University Press · United States | 3.25Q1 | 8.70 1.18 up from 2015 | 970 | 72% | $5,436 | ||
12Clinical Pharmacology & TherapeuticsWiley · United States | 2.94Q1 | 5.22 0.32 down from 2015 | 610 | 45% | $4,410 | ||
13OncologyKarger Publishers · Switzerland | 2.88Q1 | 3.99 3.67 down from 2015 | 320 | 22% | — | ||
14European Journal of EpidemiologySpringer Science+Business Media · Italy | 2.76Q1 | 6.71 0.10 down from 2015 | 336 | 57% | $3,690 | ||
15Journal of Cancer EpidemiologyHindawi Publishing Corporation · United Kingdom | 2.65Q1 | 5.23 1.77 down from 2015 | 41 | 100% | $950 | ||
16Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.55Q1 | 9.01 0.90 down from 2015 | 296 | 27% | $4,910 | ||
17CancerWiley · United States | 2.52Q1 | 5.78 0.17 down from 2015 | 1,661 | 80% | $4,790 | ||
18Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 2.51Q1 | 7.59 2.07 up from 2015 | 75 | 100% | $2,800 | ||
19International Journal of CancerWiley · United States | 2.46Q1 | 7.50 1.53 up from 2015 | 1,845 | 84% | $5,030 | ||
20British Journal of CancerSpringer Nature · United Kingdom | 2.43Q1 | 6.84 0.38 up from 2015 | 1,876 | 100% | $5,190 | ||
21Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 2.39Q1 | 5.12 0.52 down from 2015 | 423 | 74% | — | ||
22Seminars in OncologyElsevier BV · United States | 2.32Q1 | 6.81 1.99 up from 2015 | 280 | 19% | $3,550 | ||
23Journal of Hematology & OncologyOABioMed Central · United Kingdom | 2.24Q1 | 6.83 0.44 down from 2015 | 315 | 100% | $4,990 | ||
24Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.09Q1 | 5.56 0.22 up from 2015 | 1,130 | 21% | — | ||
25Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.08Q1 | 5.81 0.02 down from 2015 | 851 | 54% | — | ||
26CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.07Q1 | 6.12 0.47 up from 2015 | 342 | 100% | $3,499 | ||
27Frontiers in OncologyOAFrontiers Media · Switzerland | 2.06Q1 | 5.85 0.50 up from 2015 | 998 | 100% | $3,801 | ||
28Breast Cancer ResearchOABioMed Central · United Kingdom | 2.05Q1 | 6.96 1.76 up from 2015 | 577 | 100% | $4,190 | ||
29The OncologistOAAlphaMed Press · United Kingdom | 2.01Q1 | 4.86 0.05 down from 2015 | 609 | 99% | $3,852 | ||
30Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 1.93Q1 | 4.19 0.71 down from 2015 | 99 | 100% | $2,800 | ||
31JNCI MonographsOxford University Press · United Kingdom | 1.91Q1 | 5.00 0.93 up from 2015 | 91 | — | — | ||
32Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.88Q1 | 4.51 1.34 down from 2015 | 107 | 33% | — | ||
33Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.86Q1 | 5.13 0.91 down from 2015 | 410 | 26% | $4,190 | ||
34Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.84Q1 | 5.03 0.58 down from 2015 | 372 | 100% | $4,590 | ||
35The Cancer JournalLippincott Williams & Wilkins · United States | 1.82Q1 | 4.99 0.48 up from 2015 | 210 | 32% | — | ||
36Cancer Management and ResearchOADove Medical Press · New Zealand | 1.77Q1 | 4.73 0.10 down from 2015 | 117 | 100% | $2,836 | ||
37Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.70Q1 | 4.65 0.29 up from 2015 | 896 | 32% | — | ||
38Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 1.70Q1 | 4.49 0.14 down from 2015 | 440 | 74% | — | ||
39Cancer Research and TreatmentOAKorean Cancer Association · South Korea | 1.69Q1 | 3.89 0.06 down from 2015 | 317 | 100% | — | ||
40Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.66Q1 | 4.43 0.86 up from 2015 | 208 | 9% | $3,950 | ||
41Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.66Q1 | 3.41 0.55 down from 2015 | 675 | 9% | — | ||
42JAK-STATTaylor & Francis · United Kingdom | 1.65Q1 | 3.35 1.20 down from 2015 | 97 | 100% | — | ||
43World Journal of Gastrointestinal OncologyOAUnited States | 1.64Q1 | 4.16 0.19 up from 2015 | 135 | 100% | — | ||
44Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.63Q1 | 2.91 1.09 down from 2015 | 74 | 71% | $4,090 | ||
45Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.57Q1 | 3.60 0.15 down from 2015 | 418 | 29% | — | ||
46Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.57Q1 | 3.69 0.50 down from 2015 | 276 | 14% | — | ||
47BMC CancerOABioMed Central · United Kingdom | 1.53Q1 | 4.01 0.21 down from 2015 | 2,632 | 100% | $3,390 | ||
48Cancer MedicineOAWiley · United Kingdom | 1.53Q1 | 3.83 0.16 up from 2015 | 492 | 100% | $4,700 | ||
49Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.52Q1 | 3.10 0.35 down from 2015 | 670 | 11% | — | ||
50World Journal of Clinical OncologyOABaishideng Publishing Group · United States | 1.51Q1 | 4.09 0.53 down from 2015 | 167 | 100% | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery821
- Pulmonary and Respiratory Medicine315
- Public Health, Environmental and Occupational Health256
- Cardiology and Cardiovascular Medicine248
- Oncology198
- Infectious Diseases189
- Epidemiology187
- Endocrinology, Diabetes and Metabolism151
- Neurology151
- Radiology, Nuclear Medicine and Imaging142
- Psychiatry and Mental health134
- Physiology131
- Orthopedics and Sports Medicine102
- Pediatrics, Perinatology and Child Health91
- Ophthalmology80
- Dermatology78
- Hematology70
- Obstetrics and Gynecology64
- Rheumatology58
- Nephrology53
- Reproductive Medicine46
- Pharmacology44
- Complementary and alternative medicine43
- Emergency Medicine37
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation31
- Pathology and Forensic Medicine24
- Critical Care and Intensive Care Medicine23
- Hepatology21
- Genetics20
- Immunology and Allergy19
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology6
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2016. Corpus-wide, 77.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
80 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2013–2015, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2016. Publication window: 2013–2015. How these summaries are calculated
- Ranked journals
- 198
- Window papers (baseline)
- 102,921 +15.9% from indicator year 2013
- Median OJR
- 0.832 -14.5% from indicator year 2013
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2013–2015 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.